XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:              
Net (loss) income $ (5,503,979) $ (10,367,061) $ (9,663,447) $ 11,264,842 $ (15,871,040) $ 1,601,395  
Adjustments to reconcile net (loss) income to net cash used in operating activities:              
Depreciation expense         131,994 81,104  
Stock-based compensation expense         10,532,034 30,475,469  
Non-cash interest expense         159,305  
Merger transaction costs         7,099,353  
Change in fair value of convertible promissory notes     (48,468,678)  
Loss on Series A Preferred Stock issuance         799,990  
Loss on issuance of commitment shares   890,000   890,000  
Change in fair value of warrants 21,410   (38,788)   7,553 (6,815)  
Issuance of written call option         375,000  
Change in fair value of written call option derivative liabilities         (161,786)  
Amortization of right-of-use asset         264,192 117,189  
Change in operating assets and liabilities:              
Prepaid expenses and other assets         (297,763) (479,471)  
Other assets         9,957 (68,446)  
Accounts payable         (959,943) 3,151,676  
Accrued expenses and other liabilities         (71,206) (589,529)  
Operating lease liabilities         (243,544) (122,091)  
Net cash used in operating activities         (6,497,766) (5,146,335)  
Cash flows from investing activities:              
Purchases of property and equipment          
Net cash used in investing activities          
Cash flows from financing activities:              
Cash acquired in connection with the reverse recapitalization         229,328  
Proceeds from issuance of Series A Preferred Stock         2,000,000  
Nonrefundable prepaid proceeds towards anticipated Series A-1 Preferred Stock Issuance         3,000,000  
Capital contribution         2,500,000  
Proceeds from loan agreement         3,400,000  
Net cash provided by financing activities         5,900,000 5,229,328  
Net (decrease) increase in cash         (597,766) 82,993  
Cash – beginning of period   $ 1,282,995   $ 1,052,397 1,282,995 1,052,397 $ 1,052,397
Cash – end of period $ 685,229   $ 1,135,390   685,229 1,135,390 $ 1,282,995
Supplementary disclosure of noncash investing and financing activities:              
Conversion of convertible promissory notes into common stock in connection with Merger         46,622,627  
Repurchase of Series B preferred stock         3,613,000  
Issuance of common stock for net liabilities upon reverse recapitalization, net of transaction costs         (3,113,309)  
Right-of-use assets obtained in exchange for operating lease liabilities         $ 1,513,607